Ernexa Therapeutics (ERNA) Notes Payables (2013 - 2025)
Ernexa Therapeutics (ERNA) recorded Notes Payables of $2.25 million in Q1 2025.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) Notes Payables (2013 - 2025) Analysis & Trends
At the end of FY2013, Ernexa Therapeutics reported Notes Payables of $631,000.
- The Q1 2025 figure is the lowest quarterly Notes Payables since Q3 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Ernexa Therapeutics | 2.45 Mn | -16.70 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 2.25 Mn |
| Sep 30, 2014 | 1.82 Mn |
| Mar 31, 2014 | 702,000.00 |
| Dec 31, 2013 | 631,000.00 |
API Access
Ernexa Therapeutics Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();